Orange Book product · Generic (ANDA)
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE
EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
Generic (ANDA)ANDA 214216TE ABRX MACLEODS PHARMS LTD
At a glance
Apr 07, 2026
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Apr 07, 2026
2 mo ago
Today
Pharmaceutical detail
Active ingredient
EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
Strength
200MG;EQ 25MG BASE
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 214216
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
